Phil Grayeski

Phil Grayeski is an accomplished professional in the venture capital and biotechnology sectors, currently serving as a Partner at KdT Ventures since April 2018 and holding various board observer and member positions at companies such as Radar Therapeutics, Tacit Therapeutics, and Torque Bio. In addition to these roles, Phil is a Principal and Venture Associate at ZymoChem and has been involved with multiple organizations as a board member, including Cirsium Biosciences and Perceptive Technologies. Phil co-founded Transcera Inc. and has served as a strategy advisor for Ribometrix, demonstrating a strong foundation in business analysis within the biotech industry. Phil's educational background includes a PhD in Genetics from the University of North Carolina at Chapel Hill, an M.Phil. in Bioscience Enterprise from the University of Cambridge, and a BS in Genetics and Chemistry from The University of Georgia.